AACC Speakers Seek Cost-Efficient Cardiac Biomarker Panel
This article was originally published in The Gray Sheet
Executive Summary
Healthcare cost pressures appear to be shifting the burden of stratifying potential acute coronary syndrome patients to earlier in the hospitalization process
You may also be interested in...
Study Suggests Value Of Peptide Marker In Predicting Cardiac Morbidity
A diagnostic marker generally used to measure heart failure severity can independently predict risk in patients with stable heart disease, according to a study published last week in the Journal of the American Medical Association
Study Suggests Value Of Peptide Marker In Predicting Cardiac Morbidity
A diagnostic marker generally used to measure heart failure severity can independently predict risk in patients with stable heart disease, according to a study published last week in the Journal of the American Medical Association
BioSite Launches Triage Stroke Panel In Europe, Defends BNP Test Share
BioSite's European launch of its Triage stroke panel comes as the firm faces increasing BNP test pricing pressure from Abbott Labs